Cargando…
Optimal Efficacy and Safety of Humanized Anti-Scg3 Antibody to Alleviate Oxygen-Induced Retinopathy
The retinopathy of prematurity (ROP), a neovascular retinal disorder presenting in premature infants, is the leading causes of blindness in children. Currently, there is no approved drug therapy for ROP in the U.S., highlighting the urgent unmet clinical need for a novel therapeutic to treat the dis...
Autores principales: | He, Ye, Tian, Hong, Dai, Chang, Wen, Rong, Li, Xiaorong, Webster, Keith A., Li, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745183/ https://www.ncbi.nlm.nih.gov/pubmed/35008775 http://dx.doi.org/10.3390/ijms23010350 |
Ejemplares similares
-
Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in Mice
por: Huang, Chengchi, et al.
Publicado: (2023) -
Mutations in SCG10 Are Not Involved in Hirschsprung Disease
por: Alves, Maria M. M., et al.
Publicado: (2010) -
Inhibitory effect of anti-Scg3 on corneal neovascularization: a preliminary study
por: Jin, He, et al.
Publicado: (2022) -
JNK1 phosphorylation of SCG10 determines microtubule dynamics and axodendritic length
por: Tararuk, Tatsiana, et al.
Publicado: (2006) -
SCG3 Protein Expression in Glioma Associates With less Malignancy and Favorable Clinical Outcomes
por: Wang, Yi, et al.
Publicado: (2021)